Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Pharm Biomed Anal ; 246: 116220, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-38795426

RÉSUMÉ

This work presents the application of AQbD principles to the development of a size exclusion chromatography (SEC) HPLC procedure for the determination of monoclonal antibody (mAb) product purity using state-of-the-art column technology available via the Waters™ XBridge Premier Protein SEC column. Analytical Quality by Design (AQbD) emphasizes a systematic, risk-based lifecycle approach to analytical procedure development based on sound statistical methodologies. It has recently become increasingly recommended by regulatory agencies as a response to the need for greater efficiency, improved reliability, and increased robustness among modern analytical procedures in the pharmaceutical industry. Use of an Analytical Target Profile (ATP) and formal risk assessments informed the application of Design of Experiments (DoE) to optimize this analytical procedure, as well as assess its robustness and ruggedness. Importantly, our ruggedness results demonstrated the transferability of this procedure between two laboratories within the Catalent Biologics Global Network. Application of this analytical procedure as a platform approach for evaluating mAb purity is expected to support expedited, first-in-human timelines of mAb molecules by enabling great quantitative performance with simple mobile phase buffer compositions. Taken together, this case study demonstrates the utility of adopting AQbD principles in analytical procedure development.


Sujet(s)
Anticorps monoclonaux , Chromatographie sur gel , Anticorps monoclonaux/composition chimique , Anticorps monoclonaux/analyse , Chromatographie en phase liquide à haute performance/méthodes , Chromatographie sur gel/méthodes , Reproductibilité des résultats , Contrôle de qualité , Humains , Plan de recherche , Contamination de médicament/prévention et contrôle
2.
MAbs ; 12(1): 1750794, 2020.
Article de Anglais | MEDLINE | ID: mdl-32249667

RÉSUMÉ

Glycosylation is a common post-translational modification and critical quality attribute that can modulate the efficacy of therapeutic proteins. In the production of monoclonal antibodies (mAbs), quantifying the glycoform profile is a vital characterization step. Traditional glycan analysis is time consuming and involves steps at extreme temperature or pH, which may alter glycans. Here, we describe a rapid method for glycan analysis in which glycans are released from mAb samples that are bound to protein A columns. Since host cell proteins, which may also contain glycans, were already removed, this step enables analysis of cell culture products. Glycans released from the mAb samples are then derivatized with InstantPC™ labeling agent and analyzed by HILIC-FLD-MS. To illustrate the method, the glycan profiles of six trastuzumab (Herceptin®) antibody lots and four biosimilar developmental lots were analyzed. The results derived from our novel method, which takes less than 90 min, are compared with those from a typical glycan preparation approach.


Sujet(s)
Anticorps monoclonaux/métabolisme , Produits pharmaceutiques biosimilaires/métabolisme , Polyosides/métabolisme , Trastuzumab/métabolisme , Anticorps monoclonaux/usage thérapeutique , Antinéoplasiques immunologiques/métabolisme , Antinéoplasiques immunologiques/usage thérapeutique , Produits pharmaceutiques biosimilaires/usage thérapeutique , Chromatographie en phase liquide/méthodes , Glycosylation , Humains , Spectrométrie de masse/méthodes , Reproductibilité des résultats , Trastuzumab/usage thérapeutique
3.
MAbs ; 11(6): 1089-1100, 2019.
Article de Anglais | MEDLINE | ID: mdl-31156028

RÉSUMÉ

Although peroxide and leachable metal-induced chemical modifications are among the most important quality attributes in bioprocess development, there is no mainstream characterization method covering all common modifications theoretically possible on therapeutic proteins that also gives consistent results quickly. Here, we describe a method for rapid and consistent global characterization of leachable metals- or peroxide-stressed immunoglobulin (Ig) G1 monoclonal antibodies (mAbs). Using two independent protease digestions, data-independent acquisition and data-dependent acquisition liquid chromatography high-resolution mass spectrometry, we monitored 55 potential chemical modifications on trastuzumab, a humanized IgG1 mAb. Processing templates including all observed peptides were developed on Skyline to consistently monitor all modifications throughout the stress conditions for both enzymatic digestions. The Global Characterization Data Processing Site, a universal automated data processing application, was created to batch process data, plot modification trends for peptides, generate sortable and downloadable modification tables, and produce Jmol code for three-dimensional structural models of the analyzed protein. In total, 53 sites on the mAb were found to be modified. Oxidation rates generally increased with the peroxide concentration, while leachable metals alone resulted in lower rates of modifications but more oxidative degradants. Multiple chemical modifications were found on IgG1 surfaces known to interact with FcɣRIII, complement protein C1q, and FcRn, potentially affecting activity. The combination of Skyline templates and the Global Characterization Data Processing Site results in a universally applicable assay allowing users to batch process numerous modifications. Applying this new method to stability studies will promote a broader and deeper understanding of stress modifications on therapeutic proteins.


Sujet(s)
Anticorps monoclonaux/composition chimique , Immunoglobuline G/composition chimique , Stress oxydatif , Peptides/composition chimique , Chromatographie en phase liquide , Humains , Oxydoréduction , Récepteurs du fragment Fc des IgG/composition chimique , Spectrométrie de masse en tandem
4.
Proc Natl Acad Sci U S A ; 111(11): 4055-60, 2014 Mar 18.
Article de Anglais | MEDLINE | ID: mdl-24591621

RÉSUMÉ

Mutation in leucine-rich-repeat kinase 2 (LRRK2) is a common cause of Parkinson disease (PD). A disease-causing point mutation R1441H/G/C in the GTPase domain of LRRK2 leads to overactivation of its kinase domain. However, the mechanism by which this mutation alters the normal function of its GTPase domain [Ras of complex proteins (Roc)] remains unclear. Here, we report the effects of R1441H mutation (RocR1441H) on the structure and activity of Roc. We show that Roc forms a stable monomeric conformation in solution that is catalytically active, thus demonstrating that LRRK2 is a bona fide self-contained GTPase. We further show that the R1441H mutation causes a twofold reduction in GTPase activity without affecting the structure, thermal stability, and GDP-binding affinity of Roc. However, the mutation causes a twofold increase in GTP-binding affinity of Roc, thus suggesting that the PD-causing mutation R1441H traps Roc in a more persistently activated state by increasing its affinity for GTP and, at the same time, compromising its GTP hydrolysis.


Sujet(s)
dGTPases/métabolisme , Modèles moléculaires , Mutation faux-sens/génétique , Maladie de Parkinson/génétique , Conformation des protéines , Protein-Serine-Threonine Kinases/génétique , Technique de Western , Chromatographie sur gel , Dichroïsme circulaire , Dimérisation , Électrophorèse sur gel de polyacrylamide , dGTPases/génétique , Humains , Leucine-rich repeat serine-threonine protein kinase-2 , Spectrométrie de masse , Protein-Serine-Threonine Kinases/composition chimique , Protein-Serine-Threonine Kinases/métabolisme
5.
Proc Natl Acad Sci U S A ; 110(44): 17820-5, 2013 Oct 29.
Article de Anglais | MEDLINE | ID: mdl-24127574

RÉSUMÉ

Bacillus subtilis GabR is a transcription factor that regulates gamma-aminobutyric acid (GABA) metabolism. GabR is a member of the understudied MocR/GabR subfamily of the GntR family of transcription regulators. A typical MocR/GabR-type regulator is a chimeric protein containing a short N-terminal helix-turn-helix DNA-binding domain and a long C-terminal pyridoxal 5'-phosphate (PLP)-binding putative aminotransferase domain. In the presence of PLP and GABA, GabR activates the gabTD operon, which allows the bacterium to use GABA as nitrogen and carbon sources. GabR binds to its own promoter and represses gabR transcription in the absence of GABA. Here, we report two crystal structures of full-length GabR from B. subtilis: a 2.7-Å structure of GabR with PLP bound and the 2.55-Å apo structure of GabR without PLP. The quaternary structure of GabR is a head-to-tail domain-swap homodimer. Each monomer comprises two domains: an N-terminal winged-helix DNA-binding domain and a C-terminal PLP-binding type I aminotransferase-like domain. The winged-helix domain contains putative DNA-binding residues conserved in other GntR-type regulators. Together with sedimentation velocity and fluorescence polarization assays, the crystal structure of GabR provides insights into DNA binding by GabR at the gabR and gabT promoters. The absence of GabR-mediated aminotransferase activity in the presence of GABA and PLP, and the presence of an active site configuration that is incompatible with stabilization of the GABA external aldimine suggest that a GabR aminotransferase-like activity involving GABA and PLP is not essential to its primary function as a transcription regulator.


Sujet(s)
Bacillus subtilis/composition chimique , Évolution moléculaire , Régulation de l'expression des gènes bactériens/génétique , Modèles moléculaires , Conformation des protéines , Facteurs de transcription/composition chimique , Dimérisation , Phosphate de pyridoxal/métabolisme , Facteurs de transcription/métabolisme , Acide gamma-amino-butyrique/métabolisme
6.
Cell Rep ; 3(2): 485-96, 2013 Feb 21.
Article de Anglais | MEDLINE | ID: mdl-23375370

RÉSUMÉ

Chromosomes with multiple DNA replication origins are a hallmark of Eukaryotes and some Archaea. All eukaryal nuclear replication origins are defined by the origin recognition complex (ORC) that recruits the replicative helicase MCM(2-7) via Cdc6 and Cdt1. We find that the three origins in the single chromosome of the archaeon Sulfolobus islandicus are specified by distinct initiation factors. While two origins are dependent on archaeal homologs of eukaryal Orc1 and Cdc6, the third origin is instead reliant on an archaeal Cdt1 homolog. We exploit the nonessential nature of the orc1-1 gene to investigate the role of ATP binding and hydrolysis in initiator function in vivo and in vitro. We find that the ATP-bound form of Orc1-1 is proficient for replication and implicates hydrolysis of ATP in downregulation of origin activity. Finally, we reveal that ATP and DNA binding by Orc1-1 remodels the protein's structure rather than that of the DNA template.


Sujet(s)
Protéines d'archée/métabolisme , Sulfolobus/métabolisme , Adénosine triphosphate/métabolisme , Protéines d'archée/génétique , Protéines du cycle cellulaire/génétique , Protéines du cycle cellulaire/métabolisme , Protéines de liaison à l'ADN/génétique , Protéines de liaison à l'ADN/métabolisme , Régulation négative , Génome d'archéobactérie , Hydrolyse , Mutation , Protéines nucléaires/génétique , Protéines nucléaires/métabolisme , Complexe ORC/génétique , Complexe ORC/métabolisme , Liaison aux protéines , Sulfolobus/génétique
7.
FEBS Lett ; 587(2): 142-9, 2013 Jan 16.
Article de Anglais | MEDLINE | ID: mdl-23178717

RÉSUMÉ

Clathrin is a trimeric protein involved in receptor-mediated-endocytosis, but can function as a non-trimer outside of endocytosis. We have discovered that the subcellular distribution of a clathrin cysteine mutant we previously studied is altered and a proportion is also localized to nuclear spaces. MALS shows C1573A hub is a mixture of trimer-like and detrimerized molecules. The X-ray structure of the trimerization domain reveals that without light chains, a helix harboring cysteine-1573 is reoriented. We propose clathrin has a detrimerization switch, which suggests clathrin topology can be altered naturally for new functions.


Sujet(s)
Clathrine/composition chimique , Clathrine/métabolisme , Substitution d'acide aminé , Animaux , Bovins , Lignée cellulaire tumorale , Noyau de la cellule/métabolisme , Clathrine/génétique , Cristallographie aux rayons X , Endocytose/physiologie , Cellules HEK293 , Cellules HeLa , Humains , Lumière , Cellules MCF-7 , Modèles moléculaires , Mutagenèse dirigée , Protéines mutantes/composition chimique , Protéines mutantes/génétique , Protéines mutantes/métabolisme , Fragments peptidiques/composition chimique , Fragments peptidiques/génétique , Fragments peptidiques/métabolisme , Structure quaternaire des protéines , Structure secondaire des protéines , Structure tertiaire des protéines , Protéines recombinantes/composition chimique , Protéines recombinantes/génétique , Protéines recombinantes/métabolisme , Diffusion de rayonnements
8.
J Chem Phys ; 120(15): 6922-9, 2004 Apr 15.
Article de Anglais | MEDLINE | ID: mdl-15267590

RÉSUMÉ

The v(HF)=3 levels of the linear OC-HF complex are observed in the range of 10,800-11,500 cm(-1) using intracavity Ti-sapphire laser-induced fluorescence. The vibrational predissociation linewidths of both (30000) and (3001(1)0) states exceed 5 GHz; thus, the measured spectra are not rotationally resolvable. Under the assumption that these levels are not strongly perturbed, the rotational constants of the two levels are determined to be 0.1100(1) cm(-1) for (30000), 0.1081(1), and 0.1065(1) cm(-1) for f and e sublevels of (3001(1)0), respectively, through band contour fitting. The (30000)<--(00000) band origin is at 10,894.46(1) cm(-1), showing a HF wave number redshift of 478.3 cm(-1). The 4.07 redshift ratio of v(HF)=3 to that of v(HF)=1 indicates a significantly nonlinear increase of the intermolecular interaction energy through HF valence excitation. An ab initio interaction potential surface for HF valence coordinates varying from 0.8 to 1.25 A is used to examine vibrational dynamics. The HF valence vibration v(1) is treated perturbatively, showing that the vibrational redshifts are determined essentially in first order with only a very small second-order contribution. The (3001(1)0)<--(00000) combination transition is observed with the band origin at 11,432.66(1) cm(-1), giving the HF intermolecular bending mode to be 538.2 cm(-1). The high frequency of this vibration, compared to that in similar HF complexes, shows the strong angular anisotropy of the intermolecular interaction potential of OC-HF with respect to the HF subunit. The lifetime of the (3001(1)0) level increases to 28 ps from 14 ps for (30000).

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE